Bostongene Corporation has a total of 118 patents globally, out of which 51 have been granted. Of these 118 patents, more than 89% patents are active. The United States of America is where Bostongene Corporation has filed the maximum number of patents, followed by Europe and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Bostongene Corporation.
Bostongene Corporation was founded in 2015 by Andrew Feinberg. Bostongene Corporation provides health care software. The Company uses biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. Bostongene Corporation serves customers in the United States.
Do read about some of the most popular patents of Bostongene Corporation which have been covered by us in this article and also you can find Bostongene Corporation patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Bostongene Corporation patent portfolio.
How many patents does the Founder and CEO of Bostongene Corporation have?
The Founder and CEO Andrew Feinberg have 7 patents.
How many patents does Bostongene Corporation have?
Bostongene Corporation has a total of 118 patents globally. These patents belong to 21 unique patent families. Out of 118 patents, 106 patents are active.
How Many Patents did Bostongene Corporation File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | BostonGene Applications Filed | BostonGene Patents Granted |
2017 | 1 | – |
2018 | 47 | – |
2019 | 30 | 8 |
2020 | 22 | 22 |
2021 | 17 | 8 |
2022 | 1 | 13 |
How many Bostongene Corporation patents are Alive/Dead?
Worldwide Patents
How Many Patents did Bostongene Corporation File in Different Countries?
Countries in which Bostongene Corporation Filed Patents
Country | Patent |
United States Of America | 43 |
Japan | 8 |
Canada | 7 |
United Kingdom | 7 |
Singapore | 7 |
Australia | 6 |
Europe | 9 |
Israel | 4 |
Hong Kong (S.A.R.) | 3 |
Korea (South) | 3 |
Brazil | 2 |
China | 2 |
Germany | 2 |
India | 2 |
Mexico | 2 |
Where are Research Centers of Bostongene Corporation Patents Located?
10 Best Bostongene Corporation Patents
US10311967B2 is the most popular patent in the Bostongene Corporation portfolio. It has received 24 citations so far from companies like Roche Holding Ag and Capital One Services Llc.
Below is the list of 10 most cited patents of BostonGene :
Publication Number | Citation Count |
US10311967B2 | 19 |
US20180357361A1 | 19 |
US20180358125A1 | 15 |
US20180358132A1 | 13 |
US10340031B2 | 11 |
US10340030B2 | 10 |
WO2018231771A1 | 10 |
US10650911B2 | 8 |
US10580517B2 | 6 |
USD892825S1 | 6 |
What Percentage of Bostongene US Patent Applications were Granted?
Bostongene Corporation (Excluding its subsidiaries) has filed 31 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 16 have been granted leading to a grant rate of 84.21%.
Below are the key stats of the Bostongene Corporation’s patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for BostonGene?
Law Firm | Total Applications | Success Rate |
Wolf Greenfield & Sacks Pc | 31 | 84.21% |
EXCLUSIVE INSIGHTS COMING SOON!